EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 7

Honeybush Cyclopia intermedia E.Mey.

Also called: honeybush tea, Cyclopia spp. (also C. subternata, C. genistoides, C. maculata), Cyclopia vogelii var. intermedia (E.Mey.) Harv. (synonym)

Honeybush is a herbal tea made from Cyclopia shrubs endemic to southern Africa, including C. intermedia and C. subternata. A 2007 review found no human studies; later small trials examined skin.

Category
Botanical
Part used
Leaves and stems, as tea (fermented or green) or extract
Strongest evidence
C Limited
Native range
Native to the southern Cape Provinces of South Africa (WCVP, the taxonomic index behind POWO: "S. Cape Prov."); Cyclopia species are endemic to southern Africa
Reviewed
2026-10-29

Class 3 Limited studies in people. This entry cites 2 RCTs of honeybush alone: an oral fermented Cyclopia intermedia extract versus placebo for skin aging (120 adults), and C. maculata or C. genistoides creams versus placebo with randomized application sites in 16 women (route: topical). [2]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Honeybush does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Honeybush, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Facial wrinkles and skin aging (oral extract)CIn one 12-week randomized, placebo-controlled trial in 120 Korean adults, 400 or 800 mg/day of fermented C. intermedia extract improved wrinkle grade, elasticity and hydration versus placebo. [2]
Skin smoothness and hydration (topical cream)CIn a 2-week forearm study, 2% C. maculata or C. genistoides creams improved skin smoothness but did not improve hydration compared with placebo; the formulations were unstable over 3 months. [3]
Other health usesDA 2007 review found no human studies of honeybush; its antioxidant, immune and chemopreventive actions come from laboratory and animal research. [1]

Main constituents: Principal polyphenols: the xanthone mangiferin and the flavanones hesperetin and isokuranetin [1]; C. subternata extract contains xanthones, benzophenones, flavanones, flavones and dihydrochalcones [4]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 400 mg/day or 800 mg/day of fermented C. intermedia extract for 12 weeks (skin trial). [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • No adverse effects of honeybush consumed as a tisane had been reported as of the 2007 review. [1]
  • No adverse effects were recorded during the 12-week skin trial. [2]
  • A 2013 minireview examined the phytoestrogenic potential of selected Cyclopia polyphenols and extracts. [5]
Quality

Identity, quality and standardization

  • In a ready-to-drink C. subternata beverage, a dihydrochalcone (HPDG) and mangiferin were the most labile compounds during storage and were proposed as shelf-life quality indicators; added citric or ascorbic acid did not make the overall phenolic profile more stable. [4]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; manufacturers and distributors have initial responsibility for their safety. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Mangiferin Xanthone (C-glycoside) [P1]
  • Hesperetin and isokuranetin Flavanones [P1]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming honeybush (Cyclopia) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of honeybush was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
  • NTP technical reports list checked 2026-10-29: no report on honeybush or Cyclopia. [P4]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination of each dietary-ingredient component (21 CFR 111.75(a)(1)(i)) — Required by the US dietary supplement cGMP rule for any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P5]
  • Mangiferin and dihydrochalcone (HPDG) content over shelf life (stability-indicating assay) — These were the most labile phenolics in a ready-to-drink C. subternata beverage and were proposed as critical quality indicators for shelf life. [P6]

Supply and conservation

  • Cyclopia genistoides — IUCN Red List: Near Threatened (NT), via GBIF species API, retrieved 2026-10-29. [P7]
  • Cyclopia intermedia (the species named in this entry): GBIF species API returns IUCN category Not Evaluated (NE), retrieved 2026-10-29. [P8]

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. McKay DL, Blumberg JB. A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia). Phytother Res 2007;21(1):1-16 (PMID 16927447), 2007-01. pubmed.ncbi.nlm.nih.gov
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications, Agents classified by the IARC Monographs, Volumes 1–142 (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  5. eCFR. 21 CFR 111.75 (Title 21 up to date as of 10/27/2026), 2026-10-27. ecfr.gov
  6. Human C, et al. Stability of labile xanthones and dihydrochalcones in a ready-to-drink honeybush beverage during storage. J Sci Food Agric 2023 (PMID 37078979), 2023-09. pubmed.ncbi.nlm.nih.gov
  7. GBIF species API: IUCN Red List category for Cyclopia genistoides, 2026-10-29. api.gbif.org
  8. GBIF species API: IUCN Red List category for Cyclopia intermedia, 2026-10-29. api.gbif.org
Sources

Sources

  1. McKay DL, Blumberg JB. A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia). Phytother Res 2007;21(1):1-16 (PMID 16927447), 2007-01. pubmed.ncbi.nlm.nih.gov
  2. Choi SY, et al. Protective effects of fermented honeybush (Cyclopia intermedia) extract (HU-018) against skin aging: a randomized, double-blinded, placebo-controlled study. J Cosmet Laser Ther 2018;20(5):313-318 (PMID 29388846), 2018-10. pubmed.ncbi.nlm.nih.gov
  3. Gerber GS, et al. Stability, clinical efficacy, and antioxidant properties of Honeybush extracts in semi-solid formulations. Pharmacogn Mag 2015;11(Suppl 2):S337-51 (PMID 26664024), 2015-10. pubmed.ncbi.nlm.nih.gov
  4. Human C, et al. Stability of labile xanthones and dihydrochalcones in a ready-to-drink honeybush beverage during storage. J Sci Food Agric 2023;103(12):5697-5708 (PMID 37078979), 2023-09. pubmed.ncbi.nlm.nih.gov
  5. Louw A, et al. Phytoestrogenic potential of Cyclopia extracts and polyphenols. Planta Med 2013;79(7):580-90 (PMID 23609108), 2013-05. pubmed.ncbi.nlm.nih.gov
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  7. WCVP (World Checklist of Vascular Plants, the taxonomic index to POWO), Darwin Core archive via GBIF species API: Cyclopia intermedia E.Mey., accepted, native range "S. Cape Prov." (retrieved 2026-10-29); synonyms from WCVP. POWO page: https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:489297-1, 2026-10-29. api.gbif.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.